The Frazier Life Sciences team invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to publics.
Blueprint Medicines Completes Acquisition of Lengo Therapeutics
Frazier Healthcare Partners Closes Oversubscribed $830 Million Life Sciences Public Fund
Frazier Healthcare Partners Announces Several Promotions on Life Sciences Team
Frazier Healthcare Partners Adds Highly Experienced Biopharmaceutical Executive to Life Sciences Team